Novartis AG (NVS) Shares Bought by Quadrant Capital Management LLC
Quadrant Capital Management LLC boosted its holdings in Novartis AG (NYSE:NVS) by 5.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,047 shares of the company’s stock after purchasing an additional 1,175 shares during the period. Quadrant Capital Management LLC’s holdings in Novartis AG were worth $438,000 as of its most recent SEC filing.
Other hedge funds have also bought and sold shares of the company. City Holding Co. boosted its position in Novartis AG by 4.6% in the second quarter. City Holding Co. now owns 1,217 shares of the company’s stock worth $102,000 after purchasing an additional 54 shares during the last quarter. WFG Advisors LP boosted its position in Novartis AG by 38.1% in the second quarter. WFG Advisors LP now owns 1,221 shares of the company’s stock worth $102,000 after purchasing an additional 337 shares during the last quarter. Cable Hill Partners LLC boosted its position in Novartis AG by 588.8% in the third quarter. Cable Hill Partners LLC now owns 1,295 shares of the company’s stock worth $112,000 after purchasing an additional 1,107 shares during the last quarter. Archford Capital Strategies LLC boosted its position in Novartis AG by 72.3% in the first quarter. Archford Capital Strategies LLC now owns 1,480 shares of the company’s stock worth $110,000 after purchasing an additional 621 shares during the last quarter. Finally, Kernodle & Katon Asset Management Group LLC boosted its position in Novartis AG by 3.4% in the first quarter. Kernodle & Katon Asset Management Group LLC now owns 1,488 shares of the company’s stock worth $111,000 after purchasing an additional 49 shares during the last quarter. 11.00% of the stock is currently owned by institutional investors and hedge funds.
Several research analysts have weighed in on NVS shares. Barclays PLC cut Novartis AG from an “equal weight” rating to an “underweight” rating in a research report on Wednesday, October 25th. BidaskClub raised Novartis AG from a “sell” rating to a “hold” rating in a research report on Saturday, August 19th. Zacks Investment Research raised Novartis AG from a “hold” rating to a “buy” rating and set a $96.00 price objective on the stock in a research report on Tuesday, September 19th. Morgan Stanley raised Novartis AG from an “underweight” rating to an “overweight” rating in a research report on Wednesday, July 26th. Finally, J P Morgan Chase & Co reaffirmed a “neutral” rating on shares of Novartis AG in a research report on Tuesday, October 31st. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the company. Novartis AG presently has an average rating of “Hold” and an average target price of $85.32.
ILLEGAL ACTIVITY WARNING: “Novartis AG (NVS) Shares Bought by Quadrant Capital Management LLC” was first published by Daily Political and is the sole property of of Daily Political. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.dailypolitical.com/2017/11/15/novartis-ag-nvs-shares-bought-by-quadrant-capital-management-llc.html.
Shares of Novartis AG (NYSE NVS) traded down $0.36 during midday trading on Wednesday, hitting $82.67. The stock had a trading volume of 632,086 shares, compared to its average volume of 2,338,525. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.08 and a quick ratio of 0.81. Novartis AG has a 1 year low of $66.93 and a 1 year high of $86.90. The stock has a market cap of $214,780.00, a PE ratio of 17.41, a PEG ratio of 2.64 and a beta of 0.72.
Novartis AG (NYSE:NVS) last released its quarterly earnings data on Tuesday, October 24th. The company reported $1.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.25 by $0.04. Novartis AG had a return on equity of 15.77% and a net margin of 13.73%. The company had revenue of $12.41 billion for the quarter, compared to analyst estimates of $12.21 billion. During the same period in the previous year, the company posted $1.23 EPS. The firm’s revenue for the quarter was up 2.4% compared to the same quarter last year. research analysts forecast that Novartis AG will post 4.75 earnings per share for the current fiscal year.
Novartis AG Company Profile
Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company’s segments include Innovative Medicines, Sandoz, Alcon and Corporate activities.
Want to see what other hedge funds are holding NVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novartis AG (NYSE:NVS).
Receive News & Ratings for Novartis AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novartis AG and related companies with MarketBeat.com's FREE daily email newsletter.